| Product Code: ETC9952792 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Premenstrual Syndrome Treatment Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Premenstrual Syndrome Treatment Market - Industry Life Cycle |
3.4 United Kingdom (UK) Premenstrual Syndrome Treatment Market - Porter's Five Forces |
3.5 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Premenstrual Syndrome Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness among women about premenstrual syndrome (PMS) and available treatment options |
4.2.2 Growing demand for non-pharmacological treatments for managing PMS symptoms |
4.2.3 Technological advancements leading to the development of innovative treatment options |
4.3 Market Restraints |
4.3.1 Limited reimbursement options for PMS treatments in the UK healthcare system |
4.3.2 Side effects associated with traditional pharmacological treatments for PMS |
4.3.3 Stigma and taboo surrounding menstrual health impacting the acceptance and adoption of treatments |
5 United Kingdom (UK) Premenstrual Syndrome Treatment Market Trends |
6 United Kingdom (UK) Premenstrual Syndrome Treatment Market, By Types |
6.1 United Kingdom (UK) Premenstrual Syndrome Treatment Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By Antidepressants, 2021- 2031F |
6.1.4 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By Diuretics, 2021- 2031F |
6.1.5 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By Pain Relievers, 2021- 2031F |
6.1.6 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By Oral Contraceptives & Ovarian Suppression Agents, 2021- 2031F |
6.1.7 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Premenstrual Syndrome Treatment Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.2.3 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By E-commerce, 2021- 2031F |
6.2.4 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Premenstrual Syndrome Treatment Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Premenstrual Syndrome Treatment Market Export to Major Countries |
7.2 United Kingdom (UK) Premenstrual Syndrome Treatment Market Imports from Major Countries |
8 United Kingdom (UK) Premenstrual Syndrome Treatment Market Key Performance Indicators |
8.1 Number of healthcare providers offering non-pharmacological PMS treatment options |
8.2 Percentage of women seeking professional help for managing PMS symptoms |
8.3 Adoption rate of innovative PMS treatment technologies in the UK market |
9 United Kingdom (UK) Premenstrual Syndrome Treatment Market - Opportunity Assessment |
9.1 United Kingdom (UK) Premenstrual Syndrome Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 United Kingdom (UK) Premenstrual Syndrome Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Premenstrual Syndrome Treatment Market - Competitive Landscape |
10.1 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Premenstrual Syndrome Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here